Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioPortfolio's Approved Drugs Database

Menadione

Menadione

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Press Releases About Menadione:

 BioPortfolio Logo
Hana Biosciences Announces New Positive Interim Efficacy Results in Pivotal rALLy Clinical Trial of Marqibo in Acute Lymphoblastic Leukemia 3rd March, 2009 Hana Biosciences
- 31% COMPLETE RESPONSE RATE - MEDIAN SURVIVAL OF 10.5 MONTHS IN COMPLETE RESPONDERS - FINAL DATA TARGETED FOR 2009 ASH ANNUAL MEETING SOUTH SAN FRANCISCO, Calif., March 3 /PRNewswire-FirstCall/ --
Hana Biosciences Announces Successful Planned Independent Safety Analysis Supports Ability to Complete Pivotal rALLy Clinical Trial of Marqibo, Its Lead Novel Anti-Cancer Compound 2nd March, 2009 Hana Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., March 2 /PRNewswire-FirstCall/ -- Hana Biosciences (Nasdaq: HNAB) today announced that an Independent Data Monitoring Committee (IDMC) has completed a planned, pre

This page has been viewed 19 times Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Menadione across BioPortfolio, or for Menadione Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.